Search Results - "Gravgaard, Karina H"

Global microRNA expression profiling of high-risk ER+ breast cancers from patients receiving adjuvant tamoxifen mono-therapy: a DBCG study by Lyng, Maria B, Lænkholm, Anne-Vibeke, Søkilde, Rolf, Gravgaard, Karina H, Litman, Thomas, Ditzel, Henrik J

“…Despite the benefits of estrogen receptor (ER)-targeted endocrine therapies in breast cancer, many tumors develop resistance. MicroRNAs (miRNAs) have been…”
Get full text

The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer by Gravgaard, Karina H., Lyng, Maria B., Laenkholm, Anne-Vibeke, Søkilde, Rolf, Nielsen, Boye Schnack, Litman, Thomas, Ditzel, Henrik J.

“…Metastases are the major cause of cancer-related deaths, but the mechanisms of the metastatic process remain poorly understood. In recent years, the…”
Get full text

Gene expression signatures that predict outcome of tamoxifen-treated estrogen receptor-positive, high-risk, primary breast cancer patients: a DBCG study by Lyng, Maria B, Lænkholm, Anne-Vibeke, Tan, Qihua, Vach, Werner, Gravgaard, Karina H, Knoop, Ann, Ditzel, Henrik J

“…Tamoxifen significantly improves outcome for estrogen receptor-positive (ER+) breast cancer, but the 15-year recurrence rate remains 30%. The aim of this study…”
Get full text

The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer by Gravgaard, Karina H, Lyng, Maria B, Laenkholm, Anne-Vibeke, Sokilde, Rolf, Nielsen, Boye Schnack, Litman, Thomas, Ditzel, Henrik J

“…Metastases are the major cause of cancer-related deaths, but the mechanisms of the metastatic process remain poorly understood. In recent years, the…”
Get full text